Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 37 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 5/23/2007


1.		Phase II/III Chemotherapy with MVP (MITO/VBL/CACP) vs CHIP vs CBDCA vs VBL/CACP vs MVP-CAMP (MITO/VBL/CACP/CTX/ADR/MTX/PCB) in Patients with Metastatic (Stage III) non-Small Cell Bronchogenic Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				no age specified				NCI				EST-1583


2.		Phase III Study with CACP vs ADR/CTX/CACP & Phase II Study with VM-26 for Disseminated Transitional Cell Urinary Tract Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				under 75				NCI				EST-1878


3.		Phase III Randomized Comparison of MTX vs Cyclosporin-A for Prevention of Graft-Versus-Host Disease in Patients with ANLL in First Remission Receiving BMT from HLA-Identical Family Members

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 to 50								FHCRC-122 NCI-V83-0098


4.		Phase III Chemoradiotherapy with CTX and TBI plus Allogeneic Marrow Transplantation and Post-Transplant MTX Immunosuppression for Hematologic Malignancies in Remission or Relapse

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								FHCRC-84 NCI-V83-0094


5.		Phase II Chemotherapy with L-PAM in Patients with Metastatic Colorectal Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				no age specified				NCI				SWOG-8373


6.		Phase I/II Pilot Combination Chemotherapy with Intraperitoneal L-PAM/CACP in Patients with Stage III/IV Ovarian Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				no age specified				NCI				EST-PD-882 EST-P-D882


7.		Phase I/II Intrapleural Combination Chemotherapy with CACP/ARA-C in Patients with Malignant Involvement of the Pleura

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				no age specified								UCSD-84124 NCI-V85-0023

Last Modified: 1/1/1988


8.		Phase I/II Master Protocol Pilot Evaluation of Single-Agent or Combination Chemotherapy for Stage III Myeloma --- High-Dose L-PAM/CTX (Summary Last Modified 01/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				over 15				NCI				CLB-8512 CALGB-8512


9.		Phase I/II High-Dose Combination Chemotherapy with CTX/ARA-C/AMSA/CACP plus TBI and Autologous Bone Marrow Therapy for Refractory Diffuse Aggressive Lymphomas and Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				no age specified				NCI				NCI-83-C-215 NCI-MB-187, NCI-T84-0257N


10.		Phase I Evaluation of Intraperitoneal ARA-C and CACP in Patients with Tumors Confined to the Abdomen and Phase II Chemotherapy with Intraperitoneal ARA-C and CACP in Patients with Ovarian Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				no age specified								RPMI-PPC-869 NCI-V85-0192

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute